Literature DB >> 9270609

Neuronal loss and plasticity in the supraoptic nucleus in Parkinson's disease.

O Ansorge1, S E Daniel, R K Pearce.   

Abstract

Disturbed circadian control of renal water excretion and blood pressure adaptation in Parkinson's disease (PD) suggest impaired hypothalamic magnocellular neurosecretion. To test the hypothesis that this may relate to specific hypothalamic pathology in PD, we studied morphometrically the neuronal population of the supraoptic nucleus (SON) in PD patients and controls. Neuronal loss in the SON of PD patients was associated with increased somatic, nuclear, and nucleolar size of remaining neurons, suggesting compensatory response of these cells. We conclude that SON pathology is a feature of PD and may account for specific signs of neurohumoral dysfunction.

Entities:  

Mesh:

Year:  1997        PMID: 9270609     DOI: 10.1212/wnl.49.2.610

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  11 in total

Review 1.  Selective neuronal vulnerability in Parkinson disease.

Authors:  D James Surmeier; José A Obeso; Glenda M Halliday
Journal:  Nat Rev Neurosci       Date:  2017-01-20       Impact factor: 34.870

2.  Abnormal suppression of arginine-vasopressin by clonidine in multiple system atrophy.

Authors:  J Kimber; L Watson; C J Mathias
Journal:  Clin Auton Res       Date:  1999-10       Impact factor: 4.435

3.  Differential α-synuclein expression contributes to selective vulnerability of hippocampal neuron subpopulations to fibril-induced toxicity.

Authors:  Esteban Luna; Samantha C Decker; Dawn M Riddle; Anna Caputo; Bin Zhang; Tracy Cole; Carrie Caswell; Sharon X Xie; Virginia M Y Lee; Kelvin C Luk
Journal:  Acta Neuropathol       Date:  2018-03-03       Impact factor: 17.088

Review 4.  Parkinson's Disease Is Not Simply a Prion Disorder.

Authors:  D James Surmeier; José A Obeso; Glenda M Halliday
Journal:  J Neurosci       Date:  2017-10-11       Impact factor: 6.167

5.  Biology of Parkinson's disease: pathogenesis and pathophysiology of a multisystem neurodegenerative disorder.

Authors:  Garrett E Alexander
Journal:  Dialogues Clin Neurosci       Date:  2004-09       Impact factor: 5.986

6.  Investigating the presence of doubly phosphorylated α-synuclein at tyrosine 125 and serine 129 in idiopathic Lewy body diseases.

Authors:  Muneera Fayyad; Daniel Erskine; Nour K Majbour; Nishant N Vaikath; Simona S Ghanem; Indulekha P Sudhakaran; Houari Abdesselem; Agaristi Lamprokostopoulou; Kostas Vekrellis; Christopher M Morris; Johannes Attems; Omar M A El-Agnaf
Journal:  Brain Pathol       Date:  2020-05-06       Impact factor: 6.508

7.  Complex I reductions in the nucleus basalis of Meynert in Lewy body dementia: the role of Lewy bodies.

Authors:  Christopher Hatton; Amy Reeve; Nichola Zoe Lax; Alasdair Blain; Yi Shiau Ng; Omar El-Agnaf; Johannes Attems; John-Paul Taylor; Doug Turnbull; Daniel Erskine
Journal:  Acta Neuropathol Commun       Date:  2020-07-09       Impact factor: 7.801

Review 8.  On Cell Loss and Selective Vulnerability of Neuronal Populations in Parkinson's Disease.

Authors:  Nicolas Giguère; Samuel Burke Nanni; Louis-Eric Trudeau
Journal:  Front Neurol       Date:  2018-06-19       Impact factor: 4.003

9.  Quantitative whole-brain 3D imaging of tyrosine hydroxylase-labeled neuron architecture in the mouse MPTP model of Parkinson's disease.

Authors:  Urmas Roostalu; Casper B G Salinas; Ditte D Thorbek; Jacob L Skytte; Katrine Fabricius; Pernille Barkholt; Linu M John; Vanessa Isabell Jurtz; Lotte Bjerre Knudsen; Jacob Jelsing; Niels Vrang; Henrik H Hansen; Jacob Hecksher-Sørensen
Journal:  Dis Model Mech       Date:  2019-11-22       Impact factor: 5.758

10.  Overexpression of Wild-Type Human Alpha-Synuclein Causes Metabolism Abnormalities in Thy1-aSYN Transgenic Mice.

Authors:  Elodie Cuvelier; Mathieu Méquinion; Coline Leghay; William Sibran; Aliçia Stievenard; Alessia Sarchione; Marie-Amandine Bonte; Christel Vanbesien-Mailliot; Odile Viltart; Kevin Saitoski; Emilie Caron; Alexandra Labarthe; Thomas Comptdaer; Pierre Semaille; Hélène Carrié; Eugénie Mutez; Bernard Gressier; Alain Destée; Marie-Christine Chartier-Harlin; Karim Belarbi
Journal:  Front Mol Neurosci       Date:  2018-10-02       Impact factor: 5.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.